Monday, January 05, 2026 | 01:08 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

ANG Lifesciences India Ltd

Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30Th September 2025.

04:08 PM, 6th Nov 2025

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Pursuant to the Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 It is hereby informed you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 14th November 2025 at 05:00 P.M. at the Registered Office of the Company situated at Darbara Complex SCO-113 District Shopping Centre B Block Ranjit Avenue Amritsar-143001 inter alia transact the following business:1. To consider and approve the Standalone and Consolidated Un-Audited Financial Results of the Company for the quarter and half year ended 30th September 2025.2. Any other business that may be necessary with the permission of Chairman.

More ANG Lifesciences India Ltd Announcements